Profil
Daniel W.
Muehl is currently a Director at Clovis Oncology UK Ltd. He previously worked as a Chief Financial Officer at Repligen Corp., International Precious Minerals Group, Inc., and Physiometrix, Inc. He also worked as a Vice President-Finance at Pharmion Corp.
and as a Chief Financial Officer at OPX Biotechnologies, Inc. and SomaLogic Operating Co., Inc. Additionally, he worked as a Principal at Ernst & Young LLP and Horwath Velez & Co. PSC.
He received his undergraduate degree from the University of Massachusetts.
Postes actifs de Daniel Muehl
| Sociétés | Poste | Début |
|---|---|---|
Clovis Oncology UK Ltd.
Clovis Oncology UK Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Muehl
| Sociétés | Poste | Fin |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Directeur Financier/CFO | 10/07/2023 |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Directeur Financier/CFO | 01/06/2015 |
| STANDARD BIOTOOLS INC. | Directeur Financier/CFO | 01/01/2015 |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology Manufactures and develops bio-based chemicals and fuels | Directeur Financier/CFO | 01/04/2014 |
| REPLIGEN CORPORATION | Directeur Financier/CFO | 01/09/2007 |
Formation de Daniel Muehl
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
International Precious Minerals Group, Inc.
International Precious Minerals Group, Inc. Precious MetalsNon-Energy Minerals Explores gold properties | Non-Energy Minerals |
Physiometrix, Inc.
Physiometrix, Inc. Medical SpecialtiesHealth Technology Manufactures equipment for general anesthesia and surgical procedures | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. BiotechnologyHealth Technology Manufactures and develops bio-based chemicals and fuels | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SomaLogic Operating Co., Inc.
SomaLogic Operating Co., Inc. Medical SpecialtiesHealth Technology Operates as a protein biomarker discovery and clinical diagnostics company | Health Technology |
Horwath Velez & Co. PSC
Horwath Velez & Co. PSC Miscellaneous Commercial ServicesCommercial Services Horwath Velez & Co. PSC is a private company based in Washington, DC. | Commercial Services |
Clovis Oncology, Inc.
Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Clovis Oncology UK Ltd.
Clovis Oncology UK Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
SomaLogic, Inc.
SomaLogic, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a protein biomarker discovery and clinical diagnostics company | Commercial Services |
















